US-China Biomedical Technology, Inc. — Operating Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d59da7fc-913f-4395-bf36-fb24ca7c1175/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2018 | $-522.1k | 2018-03-01 – 2019-02-28 | evidence 0001683168-19-001869 |
| FY 2017 | $-515.5k | 2017-03-01 – 2018-02-28 | evidence 0001683168-19-001869 |
| FY 2014 | $-218.9k | 2014-03-01 – 2015-02-28 | evidence 0001019687-15-002189 |
| FY 2013 | $-1.2M | 2011-10-18 – 2014-02-28 | evidence 0001213900-14-004195 |
| FY 2012 | $-602.5k | 2011-10-17 – 2013-05-31 | evidence 0001213900-13-003750 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
US-China Biomedical Technology, Inc. — all facts · Revenue · Net Income